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Abstract. Integrins av[33 and av[35 both mediate cell 
adhesion to vitronectin yet trigger different postligand 
binding events. Integrin av133 is able to induce cell 
spreading, migration, angiogenesis, and tumor metasta- 
sis without additional stimulators, whereas av135 re- 
quires exogenous activation of protein kinase C (PKC) 
to mediate these processes. To investigate this differ- 
ence, the ability of 133 or 135 to induce colocalization of 
intracellular proteins was assessed by immunofluores- 
cence in hamster CS-1 melanoma cells. We found that 
av135 induced colocalization of talin, ot-actinin, tensin, 
and actin very weakly relative to ~v[33. eLv135 was able 
to efficiently induce colocalization of focal adhesion ki- 
nase (FAK); however, it was unable to increase phos- 
phorylation of FAK on tyrosine. Activation of PKC by 
adding phorbol ester to av[35-expressing cells induced 
spreading, increased colocalization of tx-actinin, tensin, 
vinculin, p130  cas and actin, and triggered tyrosine phos- 
phorylation of FAK. Unexpectedly, talin colocalization 
remained low even after activation of PKC. Treatment 
of cells with the PKC inhibitor calphostin C inhibited 
spreading and the colocalization of talin, a-actinin, 
tensin, and actin for both av133 and txv135. We conclude 
that PKC regulates localization of cytoskeletal proteins 
and phosphorylation of FAK induced by etvl~5. Our re- 
suits also show that FAK can be localized independent 
of its phosphorylation and that cells can spread and in- 
duce localization of other focal adhesion proteins in the 
absence of detectable talin. 
I 
NTEGRINS mediate  adhesion  of cells to  extracellular 
matrix proteins and to other cells. During adhesion, 
they also form linkages to the cytoskeleton and regu- 
late intracellular signaling pathways, thereby coordinating 
attachment to cell architecture and gene expression (Bur- 
ridge  et  al.,  1988; Hynes,  1992; Miyamoto et  al.,  1995; 
Schwartz et al., 1995). Despite significant progress towards 
understanding  these  phenomena,  much  remains  to  be 
learned about how integrin-dependent events control cell 
functions. 
Integrins  are  heterodimers,  and  binding  specificity is 
generated by varied combinations of the 14 ~x and 8 13 sub- 
units identified to date (Hynes, 1992). Binding specificities 
show  a  high  degree  of redundancy, however,  such  that 
both integrins and their ligands bind multiple partners. Ev- 
idence is emerging that individual receptors mediate dis- 
tinct  functions  and  trigger  distinct  signaling  pathways 
(Hynes, 1992; Sastry and Horwitz, 1993; Schwartz et al., 
1995). 
After initial ligand binding, integrins recruit a number of 
signaling  and  cytoskeletal proteins  to  sites  of adhesion 
(Burridge et al.,  1988; Miyamoto et al.,  1995).  While the 
precise organization of these structures remains to be de- 
termined, ~x-actinin and talin have been shown to bind di- 
rectly to sequences in the 131 cytoplasmic domain (Horwitz 
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et  al.,  1986; Otey  et  al.,  1990).  Similar  sequences  are 
present in several other integrin 13 chains, suggesting that 
these interactions are conserved. Both c~-actinin and talin 
have been reported to bind vinculin (Belkin and Kotelian- 
sky, 1987; Wachsstock et al.,  1987),  which can associate 
with both tensin and paxillin (Wilkins et al., 1986; Turner 
et al.,  1990). Focal adhesion kinase (FAK)  1 has been re- 
ported to bind to peptides from the integrin 131 cytoplas- 
mic domain, to talin, to paxillin, and to p130  cas (Polte and 
Hanks, 1995; Bellis et al., 1995; Chen et al., 1995; Schaller 
and Parsons, 1995; Schaller et al., 1995). There is evidence 
that these linkages are subject to regulation, although the 
details are not well understood. 
Integrin function is  regulated  by cytokines and  other 
soluble factors in a variety of systems. In most cases, these 
factors modulate the avidity of integrins for their ligands, 
by altering either the conformation of the receptor or the 
lateral distribution in the plasma membrane (for review 
see Schwartz et al., 1995). Integrin av135 represents an in- 
teresting exception to this rule, since it binds very well to 
its ligand vitronectin (VN), but in the absence of exoge- 
nous soluble factors, it fails to promote cell spreading or 
migration (Wayner et al., 1991; Klemke et al.,  1994) 2. By 
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also pairs with av and binds VN but induces spreading and 
migration  in  the  same  cells  in  the  absence  of cytokines 
(Wayner et al., 1991; Filardo et al., 1995). However, upon 
stimulation with either phorbol ester or cytokines to acti- 
vate protein kinase C (PKC), av135 acquires the ability to 
mediate cell spreading and migration in vitro (Klemke et 
al., 1994; Yebra et al., 1995). This PKC-dependent activa- 
tion correlates with the ability of av135 to promote anglo- 
genesis by endothelial cells and metastasis by tumor cells 
in vivo (Friedlander et al., 1995). 2 
The aim of this study was to investigate how PKC regu- 
lates  the  function of av135. While  previous studies  sug- 
gested that PKC may alter connections to the cytoskele- 
ton,  2 the molecular mechanism explaining this observation 
remains unclear. We therefore assayed the ability of c~vl35 
to induce localization of a number of cytoskeletal and sig- 
naling proteins before and after activation of PKC. Our re- 
suits show that PKC does regulate linkages to specific cy- 
toskeletal proteins.  We  also  find  that  FAK  colocalized 
with etv135 independent of PKC but that its phosphoryla- 
tion is PKC dependent. 
Materials and Methods 
Cell Culture 
CS-1 melanoma cells transfected with cDNAs encoding either the integrin 
133 subunit or the integrin 135 subunit have been described previously (Fi- 
lardo et al., 1995).  Cells were maintained in RPMI media supplemented 
with 10% FBS (GIBCO BRL, Gaithersburg, MD). 
Reagents 
Human plasma VN was purified as previously described (Yatohgo et al., 
1988).  Fibronectin  (FN)  was prepared  from human plasma by  affinity 
chromatography on gelatin Sepharose (Miekka et al., 1982).  Rhodamine 
phalloidin was purchased from Molecular Probes (Eugene, OR). All other 
chemicals, unless otherwise noted, were obtained from Sigma Chemical 
Co. (St. Louis, MO). 
Antibodies 
The monoclonal antibodies LM609 (av133) and P1F6 (ctv135) have been 
described previously (Cheresh, 1987; Wayner et al., 1991). Monoclonal an- 
tibodies directed against vinculin and talin were purchased from Sigma 
Immunochemicals  (St. Louis, MO), as was a rabbit polyclonal antibody di- 
rected  against et-actinin. A  rabbit  polyclonal  antibody  directed  against 
tensin was a generous gift of Dr. Lan-Bo Chen. Rabbit antibodies directed 
against p130  ca~ were  a  gift from Amy Bouton  (University of Virginia, 
Charlottesville, VA), and a polyclonal rabbit antiserum directed against 
talin  was  a  gift  from  Keith  Burridge  (University  of  North  Carolina, 
Chapel Hill, NC). Two antibodies directed against FAK, the rabbit poly- 
clonal antibody BC3 and the mouse monoclonal antibody 2A7, were gen- 
erous gifts from Dr. J. Thomas Parsons. The mouse monoclonal antibody 
4G10, directed against phosphotyrosine, was purchased from Upstate Bio- 
technology, Inc.  (Lake  Placid,  NY).  Fluorescein-  or  rhodamine-conju- 
gated, affinity-purified secondary antibodies were purchased from Cappel 
Laboratories (Organon-Teknika, West Chester, PA). 
Adhesion Assays 
24-well tissue culture cluster plates (Costar Corp., Cambridge, MA) were 
coated overnight at 4°C with  10 txg/ml VN in PBS, pH 7.4.  Before use, 
wells were blocked with  10 mg/ml heat-denatured BSA. Cells were de- 
tached with trypsin and washed once in RPMI containing 1%  nuclease- 
and protease-free BSA, 10 ~g/ml aprotinin and 10 p,g/ml leupeptin (RB), 
and 250 ~g/ml soybean trypsin inhibitor. Cells were resuspended in RB and 
plated at  l05 cells/well. At times indicated, adherent cells were washed 
once with medium and three times with PBS. Cells were incubated with 
200 ~1 of a solution containing 50 mM sodium acetate, pH 5.0, 0.4% Tri- 
ton X-100, and 3 mg/ml nitrophenylphosphate (No. 104, Sigma Chemical 
Co.) for 1 h at room temperature. After the addition of 50/xl 1M NaOH to 
each well, samples were transferred to 96-well plates and the OD at 405 
nm was determined. Assays were performed in triplicate. 
Bead Conjugation 
VN at 1.5 mg/ml final concentration or FN at 0.5 mg/ml, in 50 mM borate, 
pH 9.5, with 10 ixg/ml aprotinin and 10 I~g/ml leupeptin, was conjugated to 
2  ×  108  tosyl-activated  4.5-1~m polystyrene  beads/ml  (DYNAL,  Inc.. 
Great Neck, NY). Samples were incubated for 24 h at room temperature 
with gentle rotation. Conjugated beads were washed four times with 50 
mM Tris-HCl, pH 9.5. Free tosyl groups were blocked in the same buffer 
plus aprotinin and leupeptin by incubation for 16 h at 4°C with gentle rota- 
tion. Beads were washed twice and stored in sterile PBS containing 1% 
protease-free BSA. 
Binding of Beads to Cells 
Cells in suspension were incubated with VN- or FN-coated beads as previ- 
ously described (Lewis and Schwartz, 1995),  except that RPMI was used 
instead of DME, and 10 Ixg/ml each aprotinin and leupeptin were included 
as protease inhibitors. Cells and beads were incubated for 1-2 h at 37°C. 
For activation studies, cells and beads were incubated for 30 rain at 
37°C to initiate binding. After the addition of 10 nM PMA, samples were 
incubated for an additional 30 rain. Calphostin C (200 nM) was incubated 
with suspended cells before the addition of beads, at 37°C for 30 min, un- 
der fluorescent room lighting to induce activation. 
Cell Spreading on VN 
Cells were detached with trypsin, washed in RB containing 250 ixg/ml soy- 
bean trypsin inhibitor, and allowed to attach in RB to VN-coated glass 
coverslips for 30 min at 37°C. PMA at 10 nM was added to some samples 
to induce spreading. After an additional 30 min at 37°C, all samples were 
fixed with 3.7%  formaldehyde in 0.5 M  Pipes buffer containing 1 mM 
MgCI2 and 1 mM EGTA and either photographed or processed for immu- 
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Figure  1.  Attachment  to  VN  is  equivalent  for  ~vl33  and av135. 
CS-I cells expressing ave33 or txv135 were incubated for the times 
indicated in wells coated with 10 i~g/ml VN. After adhesion, unat- 
tached cells were removed by washing, and the attached cells as- 
sayed with the phosphatase substrate nitrophenylphosphate. The 
OD  405  nm is  directly  proportional  to  cell  number.  Each  data 
point represents the mean  _  the standard deviation of triplicate 
samples. 
The Journal of Cell Biology, Volume 134, 1996  1324 Figure 2.  Spreading of avl~5 CS-1 cells on VN depends on PKC. 133-transfected  cells (A and C) or 135-transfected  cells (B and D) were 
allowed to attach to glass coverslips coated with 10 p.g/ml VN for 30 min at 37°C. PMA at 10 nM was added (C and D), and all samples 
were incubated for an additional 30 min. Cells were then fixed and Nomarski micrographs taken using Tmax 400 film. Bar, 20 p.m. 
Microscopy 
Either suspended cells  with attached beads or cells  spread on VN were 
processed for immunofluorescence as previously described  (Lewis and 
Schwartz, 1995). Samples were viewed on an inverted fluorescence micro- 
scope  (Nikon  Inc.,  Melville,  NY)  equipped  with  a  60×  oil  objective 
(Olympus Corp., Lake Success, NY). Quantitation was performed also as 
described previously (Lewis and Schwartz, 1995). Nomarski images of at- 
tached cells were obtained using a microscope equipped with a 40× objec- 
tive (model BX60; Olympus Corp.). For confocal microscopy, immunoflu- 
orescent samples were scanned with a laser confocal microscope (model 
MRC 600; Bio-Rad Labs, Hercules, CA) equipped with a 63×  objective 
(Carl Zeiss Inc.,  Thornwood, NY). Photographs were taken at the cell- 
substratum interface. 
Cell Lysates 
VN at 10 txg/ml was coated onto tissue culture plates for 2-3 h at 37°C. 
Plates were washed twice  with PBS,  blocked with 10 mg/ml denatured 
BSA for 5 min, and washed again three times.  Suspension culture plates 
were made by coating tissue culture plates with the denatured BSA. Cells 
were detached with trypsin, washed once with RB containing 250 p~g/ml 
soybean trypsin inhibitor, and  plated  in  RB  containing 10  !-Lg/ml each 
aprotinin and leupeptin. Cells were incubated at 37°C. At 30 min, 10 nM 
PMA was added to some samples with gentle swirling  to mix. Cells were 
harvested at 60 min by first placing all dishes on ice and then washing each 
three times with ice cold PBS. Each 10-cm plate of cells was lysed with 0.5 
ml RIPA buffer containing 2 mM sodium vanadate, 1 mM PMSF,  and 10 
~.g/ml each of aprotinin and leupeptin; RIPA buffer consisted of 10 mM 
Tris-Cl,  pH 7.4, with 158 mM NaCI, 0.1 mM EGTA, 1% Triton X-100, 1% 
deoxycholate, and 0.I % SDS. Cell material was scraped off the plates and 
allowed to lyse for an additional 30 min on ice. Samples were centrifuged 
for 30 min at 14,000 g, at 4°C, and the supernatants were removed. Protein 
concentrations  were  determined  using the  Pierce  BCA  assay (Pierce, 
Rockford, IL). 
Immunoprecipitations 
For each gel lane, cell lysate containing 750 ~g of protein was incubated 
with 5 I~l BC3 antibody for 1 h on ice. After the addition of 20 ~l protein 
G-Sepharose (Pierce), samples were rotated at 4°C for 4 h. Beads were 
collected  by centrifugation for I rain at 3,000 g and washed five times with 
RIPA buffer containing fresh protease inhibitors and vanadate. Immuno- 
precipitates were solubilized  by dissolving  in gel sample buffer and boiled 
for 5 rain. 
Immunoblots 
Immunoprecipitates were run on a 6% SDS-polyacrylamide gel and elec- 
trophoretically  transferred  to  nitrocellulose  paper.  Blots were blocked 
overnight at 4°C in 3% nuclease- and protease-free BSA in pH 7.0 Tris- 
buffered saline (TBS) for the 4G10 antibody and 5% milk in TBS for the 
2A7 antibody. Primary antibody incubations were for 3 h at room temper- 
ature with 1:2,000 dilutions of the 4G10 and 1:750 dilutions of the 2A7 in 
3% BSA or 3% milk,  respectively.  Blots were washed three times for 10 
rain in TBS containing 0.5% Tween 20 and incubated 2 h with a 1:3,000 di- 
lution of horseradish peroxidase-conjugated goat anti-mouse IgG (Bio- 
Source International, Camarillo, CA). Blots were again washed and visu- 
alized  using chemiluminescence (ECL kit;  Amersham Corp., Arlington 
Heights, IL) according to the manufacturer's instructions. 
Results 
Attachment of Cells to Vitronectin 
Parent CS-1 melanoma cells lack expression of both eLv133 
and etv135 and thus fail to bind vitronectin (Thomas et al., 
1993).  These cells, however, can attach to and spread on 
FN via integrin ct5131. When CS-1 cells are transfected with 
Lewis et aL Protein  Kinase C Regulates f15 lntegrin  1325 Figure 3.  Cytoskeletal recruitment by integrin ctv133 and ~vl35. VN-coated beads were incubated 60 min with CS-1 hamster melanoma 
cells expressing either av133 (A, C, and E) or av135 (B, D, and F) and then fixed. Cells in the top four panels were double-labeled with 
antibodies specific for the integrins (A and B) and with rhodamine phalloidin to stain f-actin (C and D). Cells in E and Fwere labeled 
with a single antibody specific for talin. Arrows indicate position of beads. Bar, 20 Ixm. 
expression  vectors coding  for integrin  [33  or  [35, they  ex- 
press txv[33 or etv[35 on their surfaces and acquire the abil- 
ity to attach to VN (Filardo  et al., 1995).  Transfected  cell 
populations were sorted by FACS ® to select for equivalent 
expression.  Analysis  of  these  cells  lines  by  FACS ® (Fi- 
lardo and Cheresh,  manuscript submitted  for publication) 
has  demonstrated  that  they  do  express  equivalent  levels. 
Therefore, differences observed between [33- or [35-trans- 
fected  cells  to  mediate  VN-stimulated  reorganization  of 
cytoskeletal  proteins  resulted  from  properties  of txv133 
or av[35 and were not due to differences in general levels 
of expression. 
The ability of these cell lines expressing [33 or [35 to ad- 
here  to VN  was  also  assessed.  As  shown  in  Fig.  1,  both 
types of cell adhere  well to VN with  very similar kinetics 
of  binding.  Additional  experiments  demonstrated  that 
parent  CS-1  cells showed no adhesion,  and that  adhesion 
of av[33 and etv[35 lines were inhibited  by blocking mono- 
clonal antibodies to txv[33 and etv[35, respectively (Filardo, 
E.J., and D.A. Cheresh, manuscript submitted for publica- 
tion). Thus, txv[33 and etv[35 are expressed at similar levels 
and mediate attachment to VN equally well. 
Spreading of [33 or [35 Cells on VN 
The  ability  of  [33- and  [35-transfected  cells  to  mediate 
spreading on VN was assessed. When plated in culture me- 
dium containing serum or on purified VN (Fig. 2 A), only 
the [33-transfected cells spread; [35 CS-1 cells remained ad- 
herent but entirely round  (Fig.  2 B). By contrast,  133- and 
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nous  integrin  c~5131, demonstrating  that  the  inability  to 
spread was a property of the integrin and not the cell line. 
Previous work has shown that migration, angiogenesis, 
and metastasis via integrin av135 can be induced when cells 
are stimulated to activate PKC (Klemke et al., 1994; Fried- 
lander et al., 1995). 2 To determine whether av135-contain- 
ing CS-1  cells could spread on VN after PKC activation, 
phorbol ester was added to cells attached to VN, and the 
cells were incubated for an additional 30 min. After treat- 
ment,  133-transfected  cells  were  unchanged  since  they 
spread in the absence of PMA (Fig. 2 C). However, after 
activation for 5-10 min, many of the 135-transfected cells 
were starting  to spread on VN,  and  by 30 min, most of 
these cells showed some degree of spreading  (Fig. 2 D). 
Additional experiments showed that the anti-av135  mono- 
clonal  antibody P1F6  blocked  this  spreading  event (not 
shown). Additionally, calphostin C, a specific inhibitor of 
PKC, completely blocked the effects of PMA on spreading 
mediated by either <xv133 or ~v[35 (not shown). Thus, av135 
is capable of mediating cell spreading on VN, but unlike 
c~v[33, this spreading seems to require an additional signal 
from PKC. 
Interactions of avfl5 or av[33 with 
Cytoskeletal Proteins 
To determine  why av135 fails  to  mediate  cell  spreading 
without exogenous activation of PKC, we investigated the 
ability of av135 clustered by VN-coated microbeads to in- 
duce colocalization of cytoskeletal proteins, as shown pre- 
viously for 131 and FN (Lewis and Schwartz, 1995; Miya- 
moto  et  al.,  1995).  VN-coated  beads  did  not  adhere  to 
untransfected CS-1 cells (not shown) but bound efficiently 
to either 133- or 135-transfected cells. Binding of VN-coated 
beads to cells expressing ctv133 or etv135 induced localiza- 
tion  of  both  integrins  to  the  interface  with  the  beads 
equally well (Fig. 3). As expected, etv133 clustered by VN- 
coated beads also induced colocalization of actin and talin. 
However, av135 did not induce detectable colocalization of 
either of these two proteins. Quantitation of results from 
these and additional experiments revealed that binding of 
etv133 cells to VN beads induced high levels of colocaliza- 
tion of actin, a-actinin,  talin,  tensin,  and  FAK, which  is 
consistent with its ability to promote formation of focal 
adhesions and cell spreading (Fig. 4). Clustering of ctv135 
integrin, however, induced significantly weaker colocaliza- 
tion of actin, a-actinin, talin, or tensin (P <  0.05). There- 
fore, the inability of c~vf35 to mediate spreading of cells on 
VN correlates with diminished  reorganization of key cy- 
toskeletal proteins after binding of VN beads. 
Surprisingly, ctv135 induced colocalization of FAK more 
effectively than did t~v133. The staining with the anti-FAK 
antibody was very bright, which appears to account for the 
fact that accumulation of FAK exceeded that of c~v~5. As 
a  control  for these  experiments, beads  coated  with  FN 
were bound  to cells, and localization of the cytoskeletal 
proteins was examined by immunofluorescence. FN beads 
induced similar colocalization of actin and talin, as well as 
FAK, in ctv133 and etv135 cell lines (Fig. 5). Colocalization 
of a-actinin was somewhat lower in etv135 cells. We do not 
fully understand  this  result, but it suggests  that  integrin 
Figure  4.  Quantitation  of cytoskeletal  recruitment.  Suspended 
cells expressing  either c~v[33 or av[35  were  incubated  with  VN- 
coated  polystyrene  beads,  processed  for  immunofluorescence, 
and scored for colocalization. The ordinate indicates the percent- 
age of beads  positive for immunofluorescence for each antigen. 
Data are expressed as the mean -  standard deviation from three 
separate  experiments.  Solid  bars,  [33-transfected  cells;  hatched 
bars, 135-transfected cells. 
c~v135 may exert some  dominant  negative  effect on  this 
protein. Nevertheless, these results show that the differ- 
ences in localization of actin, talin, and FAK are due to the 
different integrins and not to properties of the cell lines. 
Additional controls to test the specificity of integrin lo- 
calization were performed. They showed that FN-coated 
beads failed to induce detectable accumulation of av133 or 
av135; conversely, VN-coated beads failed to induce accu- 
mulation  of a5131 on either cell type. Finally, activation 
with PMA (see below) did not trigger any changes in the 
specificity of integrin localization (data not shown). 
Interactions of av[35 After Activation of PKC 
We next investigated if the conditions that trigger spread- 
ing of the 135-transfected cells alter the ability of av[35 to 
induce  colocalization  of  cytoskeletal  proteins.  Cells  in 
which  av135 was  clustered  with  VN-coated  beads  were 
stimulated by PMA, and samples were analyzed by immu- 
nofluorescence (Fig. 6). Stimulation of the cells with PMA 
resulted in large increases in the levels of actin, a-actinin, 
vinculin, tensin, and cas that colocalized with av135 at the 
bead-cell interface (P <  0.0005).  Unexpectedly, colocal- 
ization of talin with c~v135  remained low even after stimula- 
tion (P <  0.375).  In contrast, stimulation with PMA did 
not change  the ability of a5131 clustered with FN-coated 
beads to recruit both et-actinin and talin (not shown). 
Calphostin  C  inhibited  the  colocalization of a-actinin 
and talin with av133 and blocked the increases in colocal- 
ization of a-actinin and talin with av135 induced by PMA 
(Fig. 7). These results support the notion that the effects of 
PMA on the localization of these proteins are mediated by 
PKC and indicate that for c~v133, these cytoskeletal interac- 
tions are similarly regulated by PKC. 
Analysis of Cells by Confocal Microscopy 
Beads mimic the generation of focal adhesion sites and re- 
Lewis et al. Protein Kinase C Regulates ~5 lntegrin  1327 Figure 5.  Recruitment of proteins with fibronectin-coated beads. 
Suspended cells expressing either etv[33 or txv[35 were incubated 
with FN-coated polystyrene beads, processed for immunofluores- 
cence, and  scored for colocalization. The ordinate  indicates  the 
percentage  of beads  positive for  immunofluorescence  for each 
antigen. Data are expressed as the mean and standard  deviation. 
Solid bars, 133-transfected cells; hatched bars, 135-transfected cells. 
organization of cytoskeleton necessary for cell spreading. 
To confirm that 4.5-txm beads provide a suitable model for 
interactions with planar substrata, we examined the local- 
ization of cytoskeletal proteins using confocal microscopy 
to analyze cells plated on coverslips coated with VN (Fig. 
8). Fluorescence in the 1.0-&m section nearest the substra- 
tum was analyzed. As expected, the unstimulated, round 
~xv135 cells exhibited primarily a diffuse staining pattern for 
ew135, with  some  concentration  of  fluorescence  at  the 
edges of the cells. Staining for a-actinin, talin, and tensin 
were  also  diffuse  and  showed  only  slight  overlap  with 
av135. After activation of the cells by PMA, both cw135 and 
a-actinin became distinctly polarized and showed a  high 
degree of colocalization. Tensin also colocalized strongly 
with c~v135.  Talin, however, failed to colocalize with 135 and 
remained  diffuse.  These  results  therefore confirm those 
obtained using the bead assay. 
Phosphorylation of FAK 
We next asked if the colocalization of FAK with cw135 cor- 
relates with changes in FAK phosphorylation. We there- 
fore compared the expression levels and phosphorylation 
state of FAK for the 133- and 135-transfected cells, with and 
without activation of PKC (Fig. 9). Both 133- and 135-trans- 
fected cells express equivalent amounts of FAK, which is 
unaffected by adhesion to VN or activation by PMA (Fig. 
9 B).  As  expected, phosphorylation of FAK on tyrosine 
residues increased in etv[33 cells upon adhesion to VN, and 
showed no further increase following treatment with PMA 
(Fig. 9 A). For av135 cells, the phosphorylation of FAK re- 
mained low after attachment to VN, correlating with their 
failure to spread. After treatment with PMA to induce cell 
spreading, the phosphorylation of FAK increased several- 
fold and was now equivalent to phosphorylation in well- 
spread av133 cells (Fig. 9 C). Therefore, ligand binding to 
Figure 6.  Stimulation of c~v[35 cells with PMA. Suspended  cells 
expressing  av[35 were  incubated  with  VN-coated  polystyrene 
beads. After attachment of beads to cells, 10 nM PMA was added 
to some samples. All samples were fixed after further incubation, 
processed for immunofluorescence, and scored for colocalization. 
The ordinate indicates the percentage  of beads positive for im- 
munofluorescence  for each  antigen. Data are expressed  as the 
mean _+  standard  deviation.  Solid bars, without  PMA; hatched 
bars, with PMA. 
integrin  av[35  triggers  localization  of  FAK  but  not  its 
phosphorylation. Only after exogenous activation of PKC 
does FAK becomes phosphorylated, in parallel with cell 
spreading. 
Discussion 
Integrins mediate cell adhesion events that are critical for 
tissue morphogenesis, wound repair, and cell motility. The 
biological activity of integrins involves binding to extracel- 
lular matrix proteins and consequent reorganization of the 
actin cytoskeleton and generation of intracellular signals 
(Burridge et at., 1988; Hynes, 1992; Schwartz et al., 1995). 
The integrins av133 and av135 both bind VN but have dif- 
ferent requirements for mediating subsequent  biological 
events. Induction of cell spreading, migration, angiogene- 
sis,  and tumor cell metastasis  by cwf35 in carcinoma and 
endothelial  cells  requires  additional  activation  by  cyto- 
kines, whereas txv133 can induce these events without addi- 
tional activators (Klemke et al.,  1994; Friedlander et al., 
1995). 2 This observation is interesting in light of the fact 
that cw135 is very widely expressed in normal tissues (Feld- 
ing-Habermann and Cheresh, 1993).  In many of these tis- 
sues, unregulated cell spreading and motility would likely 
be deleterious. In comparison, expression of av133 is highly 
regulated, appearing primarily on motile cell types in vivo, 
such  as  angiogenic  endothelial  cells,  migrating  smooth 
muscle cells, and invasive melanoma cells (Clyman et al., 
1992; Brooks et al., 1994; Filardo et al., 1995). Thus, motil- 
ity mediated by both txv133 and av135 is regulated, but by 
distinct mechanisms. 
The regulation of integrins by cytokines ("inside-out sig- 
The Journal of Cell Biology, Volume 134, 1996  1328 Figure 7.  Inhibition of PKC with calphostin  C. Suspended  cells 
expressing av[33 or av135 were incubated with 200 nM calphostin 
C  for 30 min at 37°C before the addition  of VN-coated beads 
(stippled bars). PMA at 10 nM was added 5 min before the addi- 
tion of the beads (hatched and stippled bars); samples without any 
pretreatment are shown in solid bars. All samples were incubated 
with VN-coated beads,  processed for immunofluorescence,  and 
scored for colocalization.  The ordinate indicates  the percentage 
of beads positive for immunofluorescence  for each antigen. Data 
are expressed as the mean + standard deviation. 
naling") has been well-studied. The platelet integrin aIIb~3 
is activated by thrombin via PKC, and the leukocyte inte- 
grin  132 also requires cell activation.  In these cases, cyto- 
kine regulation involves modulation of the integrin affinity 
for its ligand. In other cases, adhesion of cells to immobi- 
lized ligand is regulated by changes in integrin clustering 
without changes in affinity (for review see Schwartz et al., 
1995). The unusual feature of cytokine regulation of av135 
function  is  that  ligand  binding  is  unchanged,  but  postli- 
gand binding events differ. We therefore designed experi- 
ments to investigate the molecular basis for cytokine regu- 
lation of av[35 function. 
These  experiments lead  to  several novel observations. 
First, upon binding to immobilized VN, unactivated av135 
induces  the  localized  accumulation  of  actin,  c~-actinin, 
talin,  tensin,  p130  cas, and vinculin  very poorly relative to 
integrin av133. Upon activation of PKC, c~v135 acquires the 
ability  to  recruit  actin,  a-actinin,  tensin,  vinculin,  and 
p130  cas, but  not  talin.  This suggests  that  PKC  activation 
may exert effects on the conformation or phosphorylation 
state of either the 135 cytoplasmic tail, the cytoskeletal pro- 
teins, or both. The induced colocalization of these proteins 
likely accounts for, on the molecular level, the observation 
that unlike other integrins, av135 requires exogenous acti- 
vation  of PKC  to  mediate  cell  spreading  and  migration 
(Klemke et al., 1994). 
It may be relevant that cell spreading and formation of 
focal adhesions via other integrins has been found to re- 
quire PKC (Woods and Couchman, 1992; Vuori and Ruo- 
slahti,  1993).  Adhesion of HeLa cells to collagen triggers 
release of diacylglycerol and translocation of PKC to the 
membrane fraction, and adhesion of 3T3 cells to fibronec- 
tin also triggers translocation of PKC (Chun and Jacobson, 
1992;  Vuori  and  Ruoslahti,  1993;  Auer  and  Jacobson, 
1995).  In both these systems, inhibition of PKC blocks cell 
spreading. While these events are due primarily to [31 inte- 
grins,  c~v133 is  very likely to behave similarly. Taken  to- 
gether, these results suggest that integrins such as c~v133 or 
a5131 trigger PKC themselves and so do not require addi- 
tional factors. Integrin e~v135, however, may be unable to 
trigger activation of PKC  and  therefore requires  exoge- 
nous activation. We  are currently  attempting to test this 
hypothesis. 
The  cytoplasmic  domain  of  135  is  structurally  unique 
among the integrin 13 subunits  131, 132, [33, [35, 136, and  137 
(Wayner et al., 1991; Sastry and Horwitz, 1993), which are 
otherwise quite  similar. The cytoplasmic tails  of other  [3 
subunits have been shown to interact directly with the cy- 
toskeletal proteins talin and a-actinin (Tapley et al., 1989; 
Otey et al., 1990), and regions have been defined that are 
critical for these interactions to occur (Reszka et al., 1992; 
Lewis and Schwartz, 1995; Schaller et al., 1995).  These re- 
gions include  the  two  "NPXY" sequence  motifs that  are 
predicted to form one face of a helix in 131 and other 13 sub- 
units. These sequences are important for localization of 131 
to  focal  adhesions  and  for  133-mediated  cell  migration 
(Reszka et al.,  1992;  Filardo et al.,  1995).  Indeed, for [31, 
two regions surrounding these motifs have been shown to 
mediate  interactions  either  with  a-actinin,  or  with  talin, 
actin, and FAK (Tapley et al., 1989;  Lewis and Schwartz, 
1995;  Schaller et al., 1995).  It is therefore interesting that 
the spacing between the two NPXY motifs is conserved in 
other integrins, but that 135 has an insertion that increases 
the spacing from 8 to 16 amino acid residues. The unique 
cytoplasmic tail of 135, when expressed in CHO cells as a 
chimera  with  the  extracellular  and  transmembrane  do- 
mains of [31, has been found to confer properties of [35 and 
not  131; these  properties include  increased  cell migration 
and lack of localization to focal adhesions (Pasqualini and 
Hemler, 1994).  It seems likely that this difference in pri- 
mary structure also accounts for the reduced interaction of 
c~v135 with talin. Evidently, however, av135 can still interact 
with other cytoskeletal proteins to mediate cell spreading. 
While it is known that integrins can bind directly to talin 
and to a-actinin (Horwitz et al.,  1986;  Otey et al.,  1990), 
exactly how these interactions link integrin to the actin cy- 
toskeleton is still unclear. Our data show that the interac- 
tion between ~xv135 and a-actinin appears to be regulated 
Lewis et al. Protein Kinase C Regulates [35 Integrin  1329 Figure 8.  Confocal analysis of cells on coverslips. 135-transfected cells were plated onto glass coverslips coated with 10 mg/ml VN and al- 
lowed to attach for 30 min at 37°C. PMA at 10 nM was added to some samples (right half of figure), and all samples were incubated for 
an additional 30 min. Cells were fixed, processed for immunofluorescence, and double-labeled with antibodies directed against avf35 
(P1F6) and either a-actinin, tensin, or talin. Samples were scanned with a laser confocal microscope, and photographs were taken of im- 
ages near the cell-substratum interface, csk, cytoskeletal protein (listed to left of each set of photographs). 
and to require  activation of PKC.  This is consistent with 
studies involving neutrophils, where exogenous activation 
has been shown to regulate the interaction between ot-acti- 
nin  and  132  (Pavalko and LaRoche,  1993).  It is unknown 
how activation might regulate this binding at the molecu- 
lar level or if the interaction is regulated for other 13 sub- 
units.  Our  data  also  reveal  that  av135  is  unable  to  effi- 
ciently recruit talin, with or without activation. While cells 
were  able to spread without  recruiting talin, our data do 
not exclude its importance in cell spreading or migration 
mediated by other integrins. 
Our data bear upon a  number of other issues related to 
the organization of focal contacts. For example, FAK has 
been shown  to bind peptides from the integrin 13 subunit 
cytoplasmic domain, talin, and p130  ¢as (Chen et al., 1995; 
Polte and Hanks, 1995; Schaller et al., 1995).  It is possible 
that talin or other proteins are present at undetectably low 
levels before activation of PKC. It does, however, appear 
that FAK is present in the absence of detectable levels of 
talin  or  p130  cas  and  that  upon  activation,  the  level  of 
p130  ca~  increases  without  any  increase  in  FAK.  Thus, 
within the limits of the  assay, it is unlikely that  FAK re- 
quires talin or cas for its localization. Furthermore, if FAK 
binds p130  ca~ in focal adhesions, that binding must be regu- 
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135 had no effect (Brooks et al., 1994). These two integrins 
have also been shown to regulate two distinct pathways of 
angiogenesis  (Friedlander  et  al.,  1995).  Furthermore,  un- 
like av133, av135 can direct cell migration only after activa- 
tion  of PKC,  which requires  protein  synthesis  (Yebra  et 
al., 1995). Taken together, these studies suggest that av133 
and av135 integrins initiate  distinct  events following bind- 
ing to the same ligand.  Our data provide a  molecular ex- 
planation for these phenomena. 
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Figure 9.  Phosphorylation of FAK requires stimulation by PMA. 
Cells expressing either av[33 or av[35 were either kept in suspen- 
sion or plated onto VN for 30 min; 10 nM PMA was added to 
some samples, and all samples were incubated for an additional 
30 min. Cells were lysed with RIPA buffer, and FAK was immu- 
noprecipitated  (A  and  B).  Samples were resolved on 6%  gels, 
transferred to nitrocellulose, and blots were labeled with antibod- 
ies against phosphotyrosine (mAb 4G10; A) or FAK (mAb 2A7; 
B).  Blots  were quantitated  by densitometry,  with  the  level  of 
FAK phosphorylation corrected for the amount of FAK immu- 
noprecipitated for each sample (C). Fold activation is relative to 
cells in suspension. 
lated. Our results also suggest that the associations of vin- 
culin, tensin, and cas with e~v135 do not depend on the pres- 
ence of talin. 
To our surprise, FAK was present at high levels in clus- 
ters of ~v[35 before activation, but this FAK contained low 
levels of phosphotyrosine. After activation of PKC, FAK 
phosphorylation on tyrosine increased  substantially,  con- 
sistent  with reports  that PKC regulates  both ~IIb133- and 
a5131-mediated  FAK  phosphorylation  (Vuori  and  Ruo- 
slahti, 1993; Haimovich et al., 1996). However, the colocal- 
ization of FAK did not increase further. These results lead 
to the important and novel conclusion that FAK can asso- 
ciate with  a  component of focal adhesions before and in- 
dependent  of its  activation.  This  conclusion is  consistent 
with a report that FAK can bind to the 131 cytoplasmic re- 
gion in vitro (Schaller et al.,  1995) and with results show- 
ing that FAK is localized to clusters of a5131 in the pres- 
ence of cytochalasin D  or tyrosine kinase inhibitors. 
The  integrins  av133  and  av135  have  previously  been 
shown to perform different functions. In addition to their 
differential  localization on the cell surface (Wayner et al., 
1991), an antibody blocking [33 has been shown to prevent 
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